Login
Register
BUSINESS/TECH
CLINICAL
REGULATORY
PROFILES
GRAND ROUNDS
EVENTS
Contact Us
Archives
Corticosteroid
View Related Slideshows
FDA Approves Drug to Treat Duchenne Muscular Dystrophy
Feb 10, 2017 at 08:10 am
by
Staff
On Feb. 9, the U.S. Food and Drug Administration approved Emflaza (deflazacort) tablets and oral suspension to treat patients age 5 years and older with Duchenne muscular dyst....
Read More
RECENT NEWS
TOP READS
News Software by Bondware